Articles related to SUICIDE
Bariatric Surgery Cuts All-Cause Mortality Rate Over Many Years
In a retrospectives study with a 13-month follow up, bariatric surgery patients were 16% less likely to die versus matched non-surgical counterparts. However, surgery patients were more than twice as likely to die by suicide and that risk of suicide was significantly higher in those ages 18-34.
Endocrinology, Diabetes, Metabolism November 14th 2022
Ketamine and Esketamine for Depression: Lessons Learned in Clinical Practice
This overview and discussion highlights the learnings gleaned during practice in a ketamine service unit. Discussion points include treatment considerations for the two entities, switching from IV to intranasal, and a collection of pearls.
Psychiatry November 8th 2022
Association Between Folic Acid Prescription Fills and Suicide Attempts and Intentional Self-harm Among Privately Insured US Adults
Folic acid (B9) prescription in a population of more than 800,000 individuals, yielded a suicide event rate of 4.73 per 100 000 person-months, compared with a rate of 10.61 per 100 000 person-months without folic acid.
Psychiatry October 7th 2022
Learnings from an Analysis of Suicide Notes Left by the Elderly
This report on learnings shows that it is crucial to educate primary healthcare professionals on how to spot people who may commit suicide in their later years (eg, using “The 5 Ds” — Deadly methods, Depression, Disease & Disability, Disconnectness, and Development) and how to adopt prevention measures.
Geriatrics September 19th 2022
Clinical Effectiveness of Intravenous Racemic Ketamine Infusions in a Large Community Sample of Patients with Treatment-Resistant Depression, Suicidal Ideation, and Generalized Anxiety Symptoms: A Retrospective Chart Review
SI, sadness, and anxiety symptoms could all be effectively treated with ketamine. The high rates of response and remission in population samples of TRD were comparable to those for interventional therapies. Racemic ketamine infusion as the main treatment for SI requires randomized controlled trials and comparative efficacy studies with other therapies.
Psychiatry September 19th 2022
At-Home, Sublingual Ketamine Therapy Rapidly Improves Anxiety, Depressive Symptoms
In what is thought to be the largest study to date of any type of ketamine treatment, the findings revealed that, after four sessions, 89 percent of participants reported improvement in their depression and/or anxiety symptoms. On the PHQ-9 or GAD-7 scale, 63 percent of participants saw a 50% or greater improvement. PHQ-9 remission rates were 32.6 percent and GAD-7 remission rates were 31.3 percent. Furthermore, at the end of the four weeks, 62 percent of patients who had suicidal ideation prior to treatment reported no suicidal ideation.
Psychiatry August 8th 2022